Evolving Drug Delivery in Parkinson’s Clinical Trials

Effective drug delivery represents a significant challenge in the clinical trial setting, especially for neurological disorders like Parkinson’s. Over the last decade, Parkinson's clinical trials have slowly tried to implement systems to deliver the appropriate therapeutic dose of drugs to...

6 years ago
Clinical Development,Biology,News

Evolving Drug Delivery in Parkinson’s Clinical Trials

Effective drug delivery represents a significant challenge in the clinical trial setting, especially for neurological disorders like Parkinson’s. Over the last decade, Parkinson's clinical trials have slowly tried to implement systems to deliver the appropriate therapeutic dose of drugs to...

6 years ago

Immunotherapy and biomarkers: Developments in Combination Therapy for Cancer

Over the past few years, increasing evidence has supported the role of biomarkers in immunotherapy. Combination therapy - the use of a combination of products or modalities to treat cancer - is one way to use biomarkers to reveal the...

6 years ago
Oncology,R&D,Clinical Development,Biology

Immunotherapy and biomarkers: Developments in Combination Therapy for Cancer

Over the past few years, increasing evidence has supported the role of biomarkers in immunotherapy. Combination therapy - the use of a combination of products or modalities to treat cancer - is one way to use biomarkers to reveal the...

6 years ago

Weekly News Round-up – 1/4/21

In the news this week, GSK agrees to support NOVAVAX vaccine production to meet UK targets. In other news, Amgen Inc. confirms its agreement to acquire Rodeo Therapeutics, and COVID-19 vaccine production is boosted by expansions in production with BioNtech...

6 years ago
R&D,Biomanufacturing,Clinical Operations,Weekly Roundups,Biology

Weekly News Round-up – 1/4/21

In the news this week, GSK agrees to support NOVAVAX vaccine production to meet UK targets. In other news, Amgen Inc. confirms its agreement to acquire Rodeo Therapeutics, and COVID-19 vaccine production is boosted by expansions in production with BioNtech...

6 years ago

The Challenges of Drug Delivery: An Interview With Prof. Afzal R Mohammed

Conventional drug delivery methods, such as oral and systemic administration, face issues of optimisation, and present certain challenges for physicians. Proventa spoke to Professor Afzal Ur-Rahman Mohammed, Head of Pharmaceutical Sciences at Aston University Pharmacy School, about these challenges, and...

6 years ago
R&D,Clinical Development,News

The Challenges of Drug Delivery: An Interview With Prof. Afzal R Mohammed

Conventional drug delivery methods, such as oral and systemic administration, face issues of optimisation, and present certain challenges for physicians. Proventa spoke to Professor Afzal Ur-Rahman Mohammed, Head of Pharmaceutical Sciences at Aston University Pharmacy School, about these challenges, and...

6 years ago

Evaluating methods targeting Protein-Protein Interactions: A Clinical Demand

Protein-protein interactions (PPIs) are becoming increasingly relevant in the pathology of many diseases, including cancer. The issue, however, is developing an effective way of targeting them. The latest advancements in methods targeting PPIs are designed to overcome the challenges limiting...

6 years ago
R&D,Biology

Evaluating methods targeting Protein-Protein Interactions: A Clinical Demand

Protein-protein interactions (PPIs) are becoming increasingly relevant in the pathology of many diseases, including cancer. The issue, however, is developing an effective way of targeting them. The latest advancements in methods targeting PPIs are designed to overcome the challenges limiting...

6 years ago

Weekly News Round-Up – 26/3/21

In the news this week, reports urge pharmaceutical companies to exploit the benefits of synthetic data in clinical trials. In other news, FDA fears over the safety of tanezumab compromises approval for the Pfizer/Lilly pain drug, and the COSMIC database...

6 years ago
R&D,Bioprocess,Clinical Development,Weekly Roundups,Biology

Weekly News Round-Up – 26/3/21

In the news this week, reports urge pharmaceutical companies to exploit the benefits of synthetic data in clinical trials. In other news, FDA fears over the safety of tanezumab compromises approval for the Pfizer/Lilly pain drug, and the COSMIC database...

6 years ago
Previous Page Showing 240 out of 323 Next Page
Working With us

Interested?
Reserve your space